Steve Chadban

1.1k total citations
13 papers, 647 citations indexed

About

Steve Chadban is a scholar working on Public Health, Environmental and Occupational Health, Surgery and Transplantation. According to data from OpenAlex, Steve Chadban has authored 13 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Surgery and 4 papers in Transplantation. Recurrent topics in Steve Chadban's work include Renal Transplantation Outcomes and Treatments (4 papers), Organ Donation and Transplantation (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Steve Chadban is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Organ Donation and Transplantation (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Steve Chadban collaborates with scholars based in Australia, United States and New Zealand. Steve Chadban's co-authors include Faouzi Braza, Jonathan C. Craig, Daniel R. Goldstein, Allison Tong, Sophie Brouard, Germaine Wong, John M. Rose, Alan Cass, Michelle Irving and Kirsten Howard and has published in prestigious journals such as Transplantation, Nephrology Dialysis Transplantation and BMJ Open.

In The Last Decade

Steve Chadban

13 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Chadban Australia 10 256 147 145 105 100 13 647
Yang‐Jen Chiang Taiwan 14 214 0.8× 178 1.2× 165 1.1× 71 0.7× 61 0.6× 83 713
Siah Kim Australia 12 100 0.4× 55 0.4× 64 0.4× 180 1.7× 57 0.6× 41 652
Francisco Ortega Spain 16 143 0.6× 151 1.0× 334 2.3× 211 2.0× 18 0.2× 32 816
Ahad J Ghods Iran 15 424 1.7× 282 1.9× 156 1.1× 209 2.0× 96 1.0× 28 779
Linda Abress United States 9 190 0.7× 59 0.4× 134 0.9× 112 1.1× 36 0.4× 12 436
Arwin Thomasson United States 19 248 1.0× 401 2.7× 297 2.0× 89 0.8× 33 0.3× 32 930
David Game United Kingdom 18 81 0.3× 150 1.0× 217 1.5× 104 1.0× 44 0.4× 40 1.1k
Diana A. Shellmer United States 13 146 0.6× 216 1.5× 293 2.0× 15 0.1× 64 0.6× 18 850
Awatif Alam Saudi Arabia 13 160 0.6× 70 0.5× 40 0.3× 75 0.7× 46 0.5× 25 535
F A Shaheen Saudi Arabia 12 191 0.7× 131 0.9× 89 0.6× 104 1.0× 54 0.5× 45 456

Countries citing papers authored by Steve Chadban

Since Specialization
Citations

This map shows the geographic impact of Steve Chadban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Chadban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Chadban more than expected).

Fields of papers citing papers by Steve Chadban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Chadban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Chadban. The network helps show where Steve Chadban may publish in the future.

Co-authorship network of co-authors of Steve Chadban

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Chadban. A scholar is included among the top collaborators of Steve Chadban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Chadban. Steve Chadban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nickerson, Peter, Georg A. Böhmig, Steve Chadban, et al.. (2022). Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design. Trials. 23(1). 1042–1042. 22 indexed citations
2.
Aubert, Olivier, Gillian Divard, Julio Pascual, et al.. (2021). Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study. BMJ Open. 11(10). e052138–e052138. 24 indexed citations
3.
Huuskes, Brooke M., Nicole Scholes‐Robertson, Chandana Guha, et al.. (2021). Kidney transplant recipient perspectives on telehealth during the COVID‐19 pandemic. Transplant International. 34(8). 1517–1529. 22 indexed citations
4.
Stock, Peter G., Anji Wall, James M. Gardner, et al.. (2020). Ethical Issues in the COVID Era: Doing the Right Thing Depends on Location, Resources, and Disease Burden. Transplantation. 104(7). 1316–1320. 30 indexed citations
5.
Chadban, Steve, Julian Singer, Yik Wen Loh, et al.. (2020). TARGETING INFLAMMATORY MONOCYTES BY IMMUNE-MODIFYING NANOPARTICLES PREVENTS ACUTE KIDNEY ALLOGRAFT REJECTION. Transplantation. 104(S3). S45–S45. 2 indexed citations
6.
Braza, Faouzi, Sophie Brouard, Steve Chadban, & Daniel R. Goldstein. (2016). Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nature Reviews Nephrology. 12(5). 281–290. 134 indexed citations
7.
Wong, Germaine, Aron Chakera, Jeremy R. Chapman, et al.. (2016). Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?. Transplant Infectious Disease. 19(1). 9 indexed citations
8.
Irving, Michelle, Allison Tong, Stephen Jan, et al.. (2011). Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. Nephrology Dialysis Transplantation. 27(6). 2526–2533. 195 indexed citations
9.
Ma, Jin, Hong Wu, Penghao Wang, Kate Wyburn, & Steve Chadban. (2010). HIGH-MOBILITY GROUP BOX1 (HMGB1) CONTRIBUTES TO KIDNEY ISCHEMIA REPERFUSION INJURY THROUGH TLR4 SIGNALING. Transplantation. 90. 100–100. 1 indexed citations
10.
Tong, Allison, Kirsten Howard, Stephen Jan, et al.. (2010). COMMUNITY PREFERENCES FOR THE ALLOCATION OF SOLID ORGANS FOR TRANSPLANTATION: A SYSTEMATIC REVIEW. Transplantation. 90. 555–555. 2 indexed citations
11.
Tong, Allison, Peter Sainsbury, Stacy M. Carter, et al.. (2008). Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrology Dialysis Transplantation. 23(10). 3206–3214. 117 indexed citations
12.
Chadban, Steve. (2008). New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients. Nephrology Dialysis Transplantation. 23(6). 1816–1818. 41 indexed citations
13.
Chadban, Steve, David W. Johnson, Beres Joyner, et al.. (2007). Chronic kidney disease (CKD) management in general practice. Queensland's institutional digital repository (The University of Queensland). 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026